Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced the pricing of an underwritten offering of 7,248,936 shares of its common stock at a price of $3.14 per share. After underwriting discounts and commissions and estimated offering …
Billionaires Portfolio: This week the biotech stock Idenix Pharmaceuticals Inc (NASDAQ:IDIX) was acquired by Merck …
Among the companies with shares expected to actively trade in Monday’s session are Research In Motion Ltd. (BBRY), Idenix Pharmaceuticals Inc. (IDIX) and Apollo Group ... stores “disappointing” and cut the stock to neutral from buy.
Klarman's Rising Stake Klarman would likely concede that IDIX is an atypical stock for him. In fact ... The Safer Play Yet Idenix isn't even Klarman's biggest biotech investment. Instead, it's a growing stake in Theravance (Nasdaq: THRX), …
Additionally, IDIX will receive a royalty on worldwide product sales ... Idenix estimates that this restructuring will result …
announced a deal to buy Idenix Pharmaceuticals (IDIX) for $3.85 billion, an acquisition that would give the pharmaceutical giant Idenix's array of treatments for hepatitis C. Idenix soared $16.56, or 229 percent, to $23.79. Apple's (AAPL) stock
IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 18,310,000 shares of its common …
The stock has gained 1.4% over the last year. 10. Idenix Pharmaceuticals Inc. (IDIX): Biotechnology Industry. Market cap of $581.71M. Beta at 0.23. Net insider shares purchased over the last six months at 38.08K, which is 0.06% of the …
Here are the top stories from the stock market today: 1. Deals, deals, deals in pharma and meats: Merck announced earlier this morning that it was going to acquire Idenix Pharmaceuticals (IDIX), a hepatitis C drug producer for $24.50 a …
The stock has moved up across its 50-day moving average of $15.54 today. Idenix Pharmaceuticals (IDIX) closed the previous trading session at $7.86, gapping up to open at $8.81 today. Shares have risen 7.4%, trading at a volume of …